Ask AI
ADCs for Advanced BC
Integration of Novel Antibody–Drug Conjugates in Advanced HER2-Low, Hormone Receptor–Positive, and Triple-Negative Breast Cancer

Released: November 13, 2024

Activity

Progress
1
Course Completed